Logo-bi
Editorial

1. Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies
Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(2): 65-69. doi: 10.15171/bi.2015.18
PMCID: PMC4492186     PMID: 26191499     Scopus ID: 84930410369    
Article
PDF
XML
Cited By:
3
0
2
Editorial

2. Indoleamine 2, 3-dioxygenase inhibitors in immunochemotherapy of breast cancer: challenges and opportunities
Nastran Hashemzadeh, Khosro Adibkia ORCID, Jaleh Barar* ORCID
Bioimpacts. 2019;9(1): 1-3. doi: 10.15171/bi.2019.01
PMCID: PMC6378097     PMID: 30788254     Scopus ID: 85060480524    
Article
PDF
Full Text
XML
Cited By:
5
0
2
Editorial

3. Renewed interests in carbonic anhydrase IX in relevance to breast cancer treatment
Mitra Dolatkhah, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(4): 195-197. doi: 10.15171/bi.2019.24
PMCID: PMC6879713     PMID: 31799155     Scopus ID: 85077126191    
Article
PDF
Full Text
XML
Cited By:
9
2
9
Dr. Yadollah Omidi (Pharm.D., Ph.D.) is a Professor of Pharmaceutical Sciences at TUOMS Faculty of Pharmacy, working on advanced multifunctional nanobiosystems. He has worked at Cardiff University and University of Pennsylvania. He has published over 210 papers and 18 book chapters, supervised and mentored over 100 graduate/postgraduate students/researchers.
Perspective

4. Optogenetics: A new tool for cancer investigation and treatment
Siamak Alizadeh ORCID, Abolghasem Esmaeili, Jaleh Barar ORCID, Yadollah Omidi* ORCID
BioImpacts. 2022;12(4): 295-299. doi: 10.34172/bi.2021.22179
PMCID: PMC9376163     PMID: 35975208     Scopus ID: 85137389032    
Article
PDF
Full Text
XML
Cited By:
1
0
0
Optogenetics approaches can provide us with outstanding tool to extend our understanding of how cells perceive, respond, and behave in meeting with complex signals, particularly in terms of cancer evasion from the anticancer immune system functions.
Review

5. CRISPR-Cas9 in basic and translational aspects of cancer therapy
Maryam Samareh Salavatipour ORCID, Zahra Poursalehi, Negin Hosseini Rouzbahani, Sohaib Mohammadyar, Mohammad Vasei* ORCID
Bioimpacts. 2024;14(6): 30087. doi: 10.34172/bi.2024.30087
Article
PDF
XML
Cited By:
0
0
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge